Pifithrin-mu, >=97% (HPLC), solid

Pifithrin-mu, >=97% (HPLC), solid

Application

Pifithrin-? has been used:to treat microglial cell line to analyse its neuroprotective effect on M1-like and M2-like phenotypeas heat shock protein (HSP)-70 inhibitor, to treat transfected Marc-145 cellsto inhibit heat shock cognate 70 (Hsc70) to elucidate heat shock chaperones mouse embryonic stem cells

Biochem/physiol Actions

Pifithrin-µ is an inhibitor of p53 binding and anti-apoptotic, which directly inhibits p53 binding to mitochondria as well as to Bcl-xL and Bcl-2 proteins. PFTµ rescues cells from lethal γ-irradiation-induced cell death. Because pifithrin-µ shuts down only the p53-mitochondrial pathway without affecting the transcriptional functions of p53, it is superior to pifithrin-α.

Pifithrin-?(PFT-?) has neuroprotective capabilities against cell death in a preclinical model of hypoxia-ischemia (HI)-induced neonatal encephalopathy. It inhibits nuclear factor-?B (NF-?B) pathway by inhibiting the interaction of molecular chaperone heat shock protein (HSP)-70 with its substrates.

Packaging

5, 10 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3573520 Pifithrin-mu, >=97% (HPLC), solid 100 ZZUZYEMRHCMVTB-UHFFFAOYSA-N 1S/C8H7NO2S/c9-12(10,11)7-6-8-4-2-1-3-5-8/h1-5H,(H2,9,10,11) SIGMA-ALDRICH DMSO: soluble >10 mg/mL, clear, H2O: insoluble solid ≥97% (HPLC)
£242.36 (exc VAT) per 10MG
-
+
3573521 Pifithrin-mu, >=97% (HPLC), solid 100 ZZUZYEMRHCMVTB-UHFFFAOYSA-N 1S/C8H7NO2S/c9-12(10,11)7-6-8-4-2-1-3-5-8/h1-5H,(H2,9,10,11) SIGMA-ALDRICH DMSO: soluble >10 mg/mL, clear, H2O: insoluble solid ≥97% (HPLC)
£133.99 (exc VAT) per 5MG
-
+